WASHINGTON, D.C., Aug. 3, 2026 — The latest issues of three American Psychiatric Association journals (The American Journal of Psychiatry, Psychiatric Services, and Focus) are now available online.
The August issue of The American Journal of Psychiatry brings together research on schizophrenia.
- Schizophrenia: Insights Into its Etiology and Pathophysiology
- Schizophrenia Beyond Genome-Wide Association Studies: It’s About Time
- Cognitive, Electrophysiological, and Behavioral Presentation of First-Episode Psychosis with or Without Cannabis Exposure. (Lead author Dr. Deepak D'Souza, M.B.B.S., M.D., is the guest on August's AJP Audio podcast, and AJP Deputy Editor Daniel Pine, M.D., highlights the study in this video.)
- Transcriptional Profiles of Somatostatin and Parvalbumin Interneuron Subtypes in the Human Dorsolateral Prefrontal Cortex: Implications for Schizophrenia (AJP Deputy Editor Pine highlights the study in this video.)
- Association of Fetal Gene Regulatory Gene Deletions with Poor Cognition in Schizophrenia and Community-Based Samples
- Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia
- A Proposed Expansion of the Definition of Treatment-Resistant Schizophrenia
- When Billing Codes Fall Short: Unbillable Time in Collaborative Care for Co-occurring Opioid Use and Mental Health Conditions
- Social Determinants and Trends in Involuntary Psychiatric Detentions: A Decade of Population-Based Data
- Factors Associated with Nonattendance at Nonspecialist Outpatient Mental Health Clinics: Systematic Review and Meta-Analysis
- Why Psychiatric Services Need Philosophical Literacy
- Psychiatric Hospitalization Among Adults with Intellectual and Developmental Disability
Focus "Redefining Combined Treatment in Psychiatry"
This issue of Focus, helmed by Guest Editors Andrew van der Vaart, M.D., Ph.D., and Scott Aaronson, M.D., of Sheppard Pratt, assembles articles that present combined interventions designed to produce synergistic effects and improve patient outcomes. The range of approaches presented in this issue reflects the breadth of this emerging field:
- Combined Ketamine and Cognitive-Behavioral Therapy: Leveraging Metaplasticity to Enhance Treatment
- Synergistic and Scalable: A Review of Integrated Digital and Biological Interventions
- Mechanisms of Action and Change in Psychedelic-Assisted Therapies: A Holistic Framework for Ethical, Competent Clinical Care
- Contextual Engagement to Enhance Effective Transcranial Direct Current Stimulation: A Theoretical and Mechanistic Perspective
- Combining TMS and Ketamine for Treatment-Resistant Depression: Clinical Rationale, Current Evidence, and Practical Guidance
- Ethical Issues in Combined and Novel Treatment
Journalists who wish to access the publications should email press@psych.org.
American Psychiatric Association
The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 40,400 physician members specializing in the diagnosis, treatment, prevention and research of mental illnesses. APA’s vision is to ensure access to quality psychiatric diagnosis and treatment. For more information, please visit www.psychiatry.org.
Journal
American Journal of Psychiatry